Bibliography: Substance-Related and Addictive Disorders
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
Addiction science: uncovering neurobiological complexity. Neuropharmacology 2014 Jan;76 Pt B:235–249Crossref, Google Scholar
:Personality traits and vulnerability or resilience to substance use disorders. Trends Cogn Sci 2014; 18:211–217Crossref, Google Scholar
:Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence. Subst Use Misuse 2014; 49:492–512Crossref, Google Scholar
:Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories—indications for novel treatments of addiction. Eur J Neurosci 2014; 40:2163–2182Crossref, Google Scholar
:The development and maintenance of drug addiction. Neuropsychopharmacology 2014; 39:254–262Crossref, Google Scholar
:Pettinati HM, O’Brien CP, Dundon WD: Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry 2013; 170:23–30Google Scholar
The addictive dimensionality of obesity. Biol Psychiatry 2013; 73:811–818Crossref, Google Scholar
:Volkow ND, Wang GJ, Fowler JS, et al: Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 2012; 52:321–336Google Scholar
Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35:217–238Crossref, Google Scholar
:New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Subst Abuse Rehabil 2015; 6:1–14Crossref, Google Scholar
:Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv 2014; 65:146–157Link, Google Scholar
:Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; 2:CD002207Google Scholar
:Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014; 160:38–47Google Scholar
:Thomas CP, Fullerton CA, Kim M, et al: Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv 2014; 65:158–170Google Scholar
Treatment of chronic non-cancer pain. Lancet 2011; 377:2226–2235Crossref, Google Scholar
:Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009; 10:1727–1740Crossref, Google Scholar
:Adverse health effects of marijuana use. N Engl J Med 2014; 370:2219–2227Crossref, Google Scholar
:Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci 2012; 367:3353–3363Crossref, Google Scholar
:The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther 2009; 15:84–88Crossref, Google Scholar
:Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res 2007; 94:29–36Crossref, Google Scholar
:Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003; 9:76–81Crossref, Google Scholar
:The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003; 4:873–884Crossref, Google Scholar
:Prescription stimulants' effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis. J Cogn Neurosci 2015; 27:1069–1089Crossref, Google Scholar
:Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis. Biol Psychiatry 2014; 76:603–615Crossref, Google Scholar
:Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci 2014; 264(Suppl 1):S83–S90Crossref, Google Scholar
:Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend 2014; 140:42–47Crossref, Google Scholar
:Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. Biol Psychiatry 2013; 73:219–224Crossref, Google Scholar
:Doping in sport: a review of elite athletes’ attitudes, beliefs, and knowledge. Sports Med 2013; 43:395–411Crossref, Google Scholar
:Misuse of prescription stimulants among college students: a review of the literature and implications for morphological and cognitive effects on brain functioning. Exp Clin Psychopharmacol 2013; 21:385–407Crossref, Google Scholar
:Investigating the use of stimulants in out-of-competition sport samples. J Anal Toxicol 2011; 35:613–616Crossref, Google Scholar
:Sahakian BJ, Morein-Zamir S: Neuroethical issues in cognitive enhancement. J Psychopharmacol 2011; 25:197–204Google Scholar
Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychol Med 2014; 44:2523–2535Crossref, Google Scholar
:Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health 2014; 104:1557–1565Crossref, Google Scholar
:Shahab L, Andrew S, West R: Changes in prevalence of depression and anxiety following smoking cessation: results from an international cohort study (ATTEMPT). Psychol Med 2014; 44:127–141Google Scholar
Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014; 348:g1151Crossref, Google Scholar
:Persistent heavy smoking as risk factor for major depression (MD) incidence—evidence from a longitudinal Canadian cohort of the National Population Health Survey. J Psychiatr Res 2012; 46:436–443Crossref, Google Scholar
:Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008; 10:1691–1715Crossref, Google Scholar
:Assessment and management of alcohol use disorders. BMJ 2015; 350:h715Crossref, Google Scholar
:Koob GF: Alcohol use disorders: tracts, twins, and trajectories. Am J Psychiatry 2015; 172:499–501Google Scholar
O’Brien C: In treating alcohol use disorders, why not use evidence-based treatment? Am J Psychiatry 2015; 172:305–306Google Scholar
Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism. Pharmacol Biochem Behav 2014; 123:17–24Crossref, Google Scholar
:Alcoholics Anonymous and twelve-step recovery: a model based on social and cognitive neuroscience. Am J Addict 2014; 23:300–307Crossref, Google Scholar
:Genome-wide association study of alcohol dependence: significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry 2014; 19:41–49Crossref, Google Scholar
:Pharmacotherapy for Adults with Alcohol-Use Disorders in Outpatient Settings. Comparative Effectiveness Review No. 134. AHRQ Publication No. 14-EHC029-EF. Rockville, MD, Agency for Healthcare Research and Quality, 2014. Available at effectivehealthcare.ahrq.gov/ehc/products/477/1908/alcohol-misuse-drug-therapy-report-140513.pdfGoogle Scholar
:Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database Syst Rev 2014; 12:CD009269Google Scholar
:Continuing care for patients with alcohol use disorders: a systematic review. Drug Alcohol Depend 2014; 135:9–21Crossref, Google Scholar
:Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 2013; 108:275–293Crossref, Google Scholar
: